Addressing meibomian gland dysfunction and blepharitis in general is the key to suppressing the inflammatory nature of dry eye disease (DED). However, artificial tears (AT) still play a pivotal role in the management of the condition. The amount of eye drops available can make selection overwhelming for a doctor (let alone a patient). This lecture will help optometrists choose appropriate artificial drops based on the key properties. We will also simplify when it makes sense to turn to biological drops in the management of DED.
Over 900 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Another wonderful presentation from 2 excellent speakers.
Love dry eye education
Beyond expectations!!!
Really helpful to daily eye care challenges
Biologics information was very helpful !
Learned a lot!!
Both speakers were superb. Looking forward to hear more topics with them
Excellent presentation, extremely informative.
Terrific Speakers, extremely knowledgeable
Best summary of dry eye options
Speakers: Dr. Komal Mahnia Madan and Dr. Mark Eltis
Thank you to Thea for exhibiting at this event.
This event is COPE approved for 1 hour of continuing education.
Laboratoires Théa was among the first eye care companies to introduce preservative-free products. Today, Laboratoires Théa continues its pursuit of solutions that are more efficacious, more ergonomic, and safer. By constantly innovating, Théa has become the market leader in dry eye treatments in Europe.*
In collaboration with Similasan, a Swiss-based leader in homeopathic OTC products with a focus on eye and ear products, Théa offers its technology and innovative preservative-free products to the US consumer under the iVIZIA brand of products—with iVIZIA lubricant eye drops as the foundation of the product line and formulated to cover the spectrum of dry eye relief.
*Prescription market data, Sept. 2021 – S01K without cyclosporine.